Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 203516
The licenses granted herein shall be non-exclusive with respect to Peptide A, and Licensee acknowledges and agrees that Licensor intends to grant the same or similar rights to other parties. The licenses granted herein with respect to Peptide B, Peptide C, Peptide D, Peptide E and Peptide G shall be exclusive. With respect to Peptide F shall be exclusive with respect to the rights granted only as to the marketing, sales and distribution of Peptide F by Licensee to Rodan+ Fields Dermatologists Inc.
PA TENTS, PEPTIDES, AND MINIMUM RECOMMENDED CONCENTRATIONS
1. US Patent No. 6,875.744 B2 ('Short Bioactive Peptides')
2. US Patent Application Serial No. l0 /109I 7 1 ('Short Bioactive Peptides and Methods for their Use')
3. US Patent No. 7,354,903 ('Cosmetjc Compositions Containing Short Bioactive Peptides')
The licensed properties are Short Bioactive Peptides. The different peptides contain different levels of Premix concentrations. Licensor has developed small, short-chain peptides with anti-infective, anti-inflammatory and modulatory properties such as the stimulation of cell proliferation and migration. These peptides are targeted for use as ingredients in cosmeceutical products and as new topical therapeutics.
IPSCIO Record ID: 357956
Licensee has developed and validated peptide-based and peptide-enhanced ingredient blends for skin care applications targeting improvement in the appearance of acne-prone skin or reduction of visible signs of aging such as lines, wrinkles and loss of firmness and elasticity.
IPSCIO Record ID: 273405
Primary Sequence FAKALKALLKALKAL-NH2
Patents and Patent Applications
US Patent No. 6,875,744 (Short Bioactive Peptides)
US Patent Application Serial No. 10/109171 (Short Bioactive Peptides and Methods for their Use)
US Patent Application Serial No. 10/839525 (Cosmetic compositions Containing Short Bioactive Peptides)
Product means the final, marketable cosmetic or over-the-counter personal care formulations incorporating Peptide(s) that are set forth below Additional Products may be added by agreement of the parties.
P.A.C. Perfect (Peptide-powered Acne Control) Treatment Essence â€” Opacified gel containing 1% Salicylic Acid (active ingredient), 0.1% HB64 and other excipient ingredients for treatment of facial acne.
P.A.C. Perfect Treatment Essence may be marketed as part of a set containing the following additional products not containing any Peptide P.A.C. Perfect Toning Cleanser and P.A.C. Perfect nightime Recovery Lotion (the â€œP.A.C. Perfect Setâ€).
Technology means inventions (whether or not patentable), ideas, processes, formulas and know-how owned by Licensor as of the date of this Agreement and relating to the Peptides.
IPSCIO Record ID: 1342
Licensed Peptides shall mean the 3 short chain linear peptides, the amino acid sequences.
Licensed Products shall mean any topical, non-pharmaceutical skin care intermediate concentrates and end-use products that contain one or more of the Licensed Peptides.
TPI I.D. Number Amino Acid Sequence
P 48 VAKLLAKLAKKLL
P 118 FAKLLAKALKKFL
P 165 FALALKALKKL